Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A Serological Assay for Neutralizing Antitoxin Response in Patients with Clostridium difficile Infection

Award Number: R43AI136176
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 01/20/2018
PERIOD OF PERFORMANCE END DATE: 12/31/2019

Group Awards By:

View Award Description

A Serological Assay for Neutralizing Antitoxin Response in Patients with Clostridium difficile Infection - Abstract: Clostridium difficile is responsible for more than 29,000 deaths in the US each year and the infection represents an urgent threat to public health worldwide. Of most concern is that the incidence of C. difficile infection (CDI) and disease severity is rapidly increasing in recent years due to the emergence of hypervirulent and antibiotic-resistant strains. CDI is mainly caused by two major toxins TcdA and TcdB, and toxin- neutralizing antibodies (antitoxins) are responsible for effective immunity. Therefore, it is important to measure host antitoxin responses since such information will be crucial for assisting physicians to predict CDI progression and recurrence, as well as to guide the use of antibody-based therapeutics. However, current assays to measure patient antitoxin responses are based on serum inhibition of toxins’ biological activities on cultured cells; such assays are time consuming, laborious, and difficult to standardize. We aim to develop a serological ELISA for predicting protective immunity against primary and recurrent CDI in patients. This will help clinical management of CDI and also may be used as a companion diagnostic for passive and active immunotherapies. We have identified a broadly neutralizing antibody (bNAb) N3 and established a N3-based competition ELISA in that CDI patient sera were assayed for inhibiting the binding of biotinylated N3 to TcdB. We found that those sera with high neutralizing anti-TcdB titers are also significantly more potent in inhibiting N3 binding to TcdB than sera with low neutralizing titers. In this project, we will identify additional bNAbs from a panel of anti-TcdB neutralizing antibodies we have developed and evaluate the bNAbs-based ELISA in 240 banked serum samples from CDI patients. Our ultimate goal is to develop a simple serological ELISA screen for antitoxin protective immunity, and thus help the clinical management of CDI and assist the future use of passive and active immunotherapies against this debilitating disease.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2020 ( Subtotal = $0 )
2020	2018	FZATA INC	1450 S ROLLING RD STE 4101	HALETHORPE	MD	21227	BALTIMORE	USA	Allergy and Infectious Diseases Research	000	1	5/12/2020	NEW	$0
														Subtotal = $0

Issue Date FY: 2018 ( Subtotal = $168,931 )
2018	2018	FZATA INC	1448 S ROLLING RD STE 120	HALETHORPE	MD	21227	BALTIMORE	USA	Allergy and Infectious Diseases Research	001	1	1/31/2018	NEW	$0
2018	2018	FZATA INC	1448 S ROLLING RD STE 120	HALETHORPE	MD	21227	BALTIMORE	USA	Allergy and Infectious Diseases Research	000	1	1/20/2018	NEW	$168,931
														Subtotal = $168,931

Grand Total All Awards = $168,931

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Serological Assay for Neutralizing Antitoxin Response in Patients with Clostridium difficile Infection

Award Number: R43AI136176

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 01/20/2018

PERIOD OF PERFORMANCE END DATE: 12/31/2019

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer